keyword
https://read.qxmd.com/read/36300321/nmnat2-inhibition-aggravates-neurological-damage-after-traumatic-brain-injury-in-a-rat-model
#41
JOURNAL ARTICLE
Xiaoyu Gu, Haibo Ni, XuGang Kan, Chen Chen, Zhiping Zhou, Zheng Ding, Di Li, Bofei Liu
Objective: Nicotinamide mononucleotide adenylyl transferase 2 (NMNAT2) is a crucial factor for the survival of neuron. The role of NMNAT2 in damage following traumatic brain injury (TBI) remains unknown. This study was designed to investigate the role of NMNAT2 in TBI-induced neuronal degeneration and neurological deficits in rats. Methods: The TBI model was established in Sprague -Dawley rats by a weight-dropping method. Real-time polymerase chain reaction, western blot, immunofluorescence, Fluoro-Jade C staining, and neurological score analyses were carried out...
October 27, 2022: Journal of Korean Neurosurgical Society
https://read.qxmd.com/read/36211224/systemic-lupus-erythematosus-myocarditis-after-covid-19-vaccination
#42
Miguel Sogbe, Andrés Blanco-Di Matteo, I Madeleine Di Frisco, Juan Fernando Bastidas, Nahikari Salterain, Juan José Gavira
INTRODUCTION: Cases of acute myocarditis have been after administration of the BNT162b2 and Ad26.COV2.S vaccine. OBJECTIVE: Describe another possible mechanism of myocarditis after COVID-19 vaccination. CASE PRESENTATION: We describe the clinical case of a 72-year-old female with pleuritic chest pain one week after the third of the BNT162b2 mRNA vaccine. Serological tests for cardiotropic pathogens were negative, and autoimmunity screening was positive with anti-nuclear antibody (ANA) in 1:160 dilution, Anti-double-stranded DNA (anti-dsDNA), and anti-histone antibodies...
February 2023: Reumatología Clinica
https://read.qxmd.com/read/36153384/targeting-non-coding-rna-family-members-with-artificial-endonuclease-xnazymes
#43
JOURNAL ARTICLE
Maria J Donde, Adam M Rochussen, Saksham Kapoor, Alexander I Taylor
Non-coding RNAs (ncRNAs) offer a wealth of therapeutic targets for a range of diseases. However, secondary structures and high similarity within sequence families make specific knockdown challenging. Here, we engineer a series of artificial oligonucleotide enzymes (XNAzymes) composed of 2'-deoxy-2'-fluoro-β-D-arabino nucleic acid (FANA) that specifically or preferentially cleave individual ncRNA family members under quasi-physiological conditions, including members of the classic microRNA cluster miR-17~92 (oncomiR-1) and the Y RNA hY5...
September 24, 2022: Communications Biology
https://read.qxmd.com/read/36136537/in-silico-evaluation-of-sesquiterpenes-and-benzoxazinoids-phytotoxins-against-m-pro-rna-replicase-and-spike-protein-of-sars-cov-2-by-molecular-dynamics-inspired-by-nature
#44
JOURNAL ARTICLE
Francisco J R Mejías, Alexandra G Durán, Nuria Chinchilla, Rosa M Varela, José A Álvarez, José M G Molinillo, Francisco García-Cozar, Francisco A Macías
In the work described here, a number of sesquiterpenes and benzoxazinoids from natural sources, along with their easily accessible derivatives, were evaluated against the main protease, RNA replicase and spike glycoprotein of SARS-CoV-2 by molecular docking. These natural products and their derivatives have previously shown remarkable antiviral activities. The most relevant compounds were the 4-fluoro derivatives of santamarine, reynosin and 2-amino-3 H -phenoxazin-3-one in terms of the docking score. Those compounds fulfill the Lipinski's rule, so they were selected for the analysis by molecular dynamics, and the kinetic stabilities of the complexes were assessed...
August 29, 2022: Toxins
https://read.qxmd.com/read/36064973/a-modular-xnazyme-cleaves-long-structured-rnas-under-physiological-conditions-and-enables-allele-specific-gene-silencing
#45
JOURNAL ARTICLE
Alexander I Taylor, Christopher J K Wan, Maria J Donde, Sew-Yeu Peak-Chew, Philipp Holliger
Nucleic-acid catalysts (ribozymes, DNA- and XNAzymes) cleave target (m)RNAs with high specificity but have shown limited efficacy in clinical applications. Here we report on the in vitro evolution and engineering of a highly specific modular RNA endonuclease XNAzyme, FR6_1, composed of 2'-deoxy-2'-fluoro-β-D-arabino nucleic acid (FANA). FR6_1 overcomes the activity limitations of previous DNA- and XNAzymes and can be retargeted to cleave highly structured full-length (>5 kb) BRAF and KRAS mRNAs at physiological Mg2+ concentrations with allelic selectivity for tumour-associated (BRAF V600E and KRAS G12D) mutations...
September 5, 2022: Nature Chemistry
https://read.qxmd.com/read/35931138/analysis-of-the-responsible-site-for-favipiravir-resistance-in-rna-dependent-rna-polymerase-of-influenza-virus-a-pr-8-34-h1n1-using-site-directed-mutagenesis
#46
JOURNAL ARTICLE
Takashi Komeno, Yousuke Furuta, Nozomi Nakajima, Hideki Tani, Yoshitomo Morinaga
Favipiravir (T-705, 6-fluoro-3-hydroxy-2-pyrazinecarboxamide) selectively and strongly inhibits the replication of influenza virus in vitro and in vivo. Favipiravir is converted to favipiravir-4-ribofuranosyl-5-triphosphate (favipiravir RTP) by intracellular enzymes and functions as a nucleotide analog to selectively inhibit RNA-dependent RNA polymerase (RdRP) of influenza virus. Our previous experiments failed in an attempt to obtain a favipiravir-resistant influenza virus in vitro using influenza virus A/PR/8/34(H1N1)...
August 2, 2022: Antiviral Research
https://read.qxmd.com/read/35921898/chemically-modified-dsrna-induces-rnai-effects-in-insects-in-vitro-and-in-vivo-a-potential-new-tool-for-improving-rna-based-plant-protection
#47
JOURNAL ARTICLE
John D Howard, Myriam Beghyn, Nathalie Dewulf, Yves De Vos, Annelies Philips, David Portwood, Peter M Kilby, Duncan Oliver, Wendy Maddelein, Stephen Brown, Mark J Dickman
Global agriculture loses over $100 billion of produce annually to crop pests such as insects. Many of these crop pests either are not currently controlled by artificial means or have developed resistance against chemical pesticides. Long dsRNAs are capable of inducing RNA interference (RNAi) in insects and are emerging as novel, highly selective alternatives for sustainable insect management strategies. However, there are significant challenges associated with RNAi efficacy in insects. In this study, we synthesised a range of chemically-modified long dsRNAs in an approach to improve nuclease resistance and RNAi efficacy in insects...
July 31, 2022: Journal of Biological Chemistry
https://read.qxmd.com/read/35921401/role-of-a-magic-methyl-2-deoxy-2-%C3%AE-f-2-%C3%AE-c-methyl-pyrimidine-nucleotides-modulate-rna-interference-activity-through-synergy-with-5-phosphate-mimics-and-mitigation-of-off-target-effects
#48
JOURNAL ARTICLE
Dale C Guenther, Shohei Mori, Shigeo Matsuda, Jason A Gilbert, Jennifer L S Willoughby, Sarah Hyde, Anna Bisbe, Yongfeng Jiang, Saket Agarwal, Mimouna Madaoui, Maja M Janas, Klaus Charisse, Martin A Maier, Martin Egli, Muthiah Manoharan
Although 2'-deoxy-2'-α-F-2'-β- C -methyl (2'-F/Me) uridine nucleoside derivatives are a successful class of antiviral drugs, this modification had not been studied in oligonucleotides. Herein, we demonstrate the facile synthesis of 2'-F/Me-modified pyrimidine phosphoramidites and their subsequent incorporation into oligonucleotides. Despite the C3'- endo preorganization of the parent nucleoside, a single incorporation into RNA or DNA resulted in significant thermal destabilization of a duplex due to unfavorable enthalpy, likely resulting from steric effects...
August 17, 2022: Journal of the American Chemical Society
https://read.qxmd.com/read/35793357/swarms-of-chemically-modified-antiviral-sirna-targeting-herpes-simplex-virus-infection-in-human-corneal-epithelial-cells
#49
JOURNAL ARTICLE
Kiira Kalke, Liisa M Lund, Marie C Nyman, Alesia A Levanova, Arto Urtti, Minna M Poranen, Veijo Hukkanen, Henrik Paavilainen
Herpes simplex virus type 1 (HSV-1) is a common virus of mankind and HSV-1 infections are a significant cause of blindness. The current antiviral treatment of herpes infection relies on acyclovir and related compounds. However, acyclovir resistance emerges especially in the long term prophylactic treatment that is required for prevention of recurrent herpes keratitis. Earlier we have established antiviral siRNA swarms, targeting sequences of essential genes of HSV, as effective means of silencing the replication of HSV in vitro or in vivo...
July 2022: PLoS Pathogens
https://read.qxmd.com/read/35654808/dysregulation-of-micrornas-and-trna-derived-ncrnas-in-mesothelial-and-mesothelioma-cell-lines-after-asbestiform-fiber-exposure
#50
JOURNAL ARTICLE
Veronica Filetti, Alessandro La Ferlita, Antonio Di Maria, Venera Cardile, Adriana C E Graziano, Venerando Rapisarda, Caterina Ledda, Alfredo Pulvirenti, Carla Loreto
Experimental evidence demonstrated that fluoro-edenite (FE) can develop chronic respiratory diseases and elicit carcinogenic effects. Environmental exposure to FE fibers is correlated with malignant pleural mesothelioma (MPM). An early diagnosis of MPM, and a comprehensive health monitoring of the patients exposed to FE fibers are two clinical issues that may be solved by the identification of specific biomarkers. We reported the microRNA (miRNA) and transfer RNA-derived non coding RNA (tRNA-derived ncRNA) transcriptome in human normal mesothelial and malignant mesothelioma cell lines exposed or not exposed to several concentration FE fibers...
June 2, 2022: Scientific Reports
https://read.qxmd.com/read/35544615/identification-of-genes-essential-for-sulfamate-and-fluorine-incorporation-during-nucleocidin-biosynthesis
#51
JOURNAL ARTICLE
Aleksandra Pasternak, Andreas Bechthold, David L Zechel
Nucleocidin is an adenosine derivative containing 4'-fluoro and 5'-O-sulfamoyl substituents. In this study, nucleocidin biosynthesis is examined in two newly discovered producers, Streptomyces virens B-24331 and Streptomyces aureorectus B-24301, which produce nucleocidin and related derivatives at titres 30-fold greater than S. calvus . This enabled the identification of two new O -acetylated nucleocidin derivatives, and a potential glycosyl- O-acetyltransferase. Disruption of nucJ , nucG , and nucI , within S...
May 11, 2022: Chembiochem: a European Journal of Chemical Biology
https://read.qxmd.com/read/35482908/clinical-advances-of-rna-therapeutics-for-treatment-of-neurological-and-neuromuscular-diseases
#52
JOURNAL ARTICLE
Anja Holm, Stine N Hansen, Henrik Klitgaard, Sakari Kauppinen
RNA therapeutics comprise a diverse group of oligonucleotide-based drugs such as antisense oligonucleotides (ASOs), small interfering RNAs (siRNAs), and short hairpin RNAs (shRNAs) that can be designed to selectively interact with drug targets currently undruggable with small molecule-based drugs or monoclonal antibodies. Furthermore, RNA-based therapeutics have the potential to modulate entire disease pathways, and thereby represent a new modality with unprecedented potential for generating disease-modifying drugs for a wide variety of human diseases, including central nervous system (CNS) disorders...
2022: RNA Biology
https://read.qxmd.com/read/35110538/a-dual-mechanism-of-action-of-at-527-against-sars-cov-2-polymerase
#53
JOURNAL ARTICLE
Ashleigh Shannon, Véronique Fattorini, Bhawna Sama, Barbara Selisko, Mikael Feracci, Camille Falcou, Pierre Gauffre, Priscila El Kazzi, Adrien Delpal, Etienne Decroly, Karine Alvarez, Cécilia Eydoux, Jean-Claude Guillemot, Adel Moussa, Steven S Good, Paolo La Colla, Kai Lin, Jean-Pierre Sommadossi, Yingxiao Zhu, Xiaodong Yan, Hui Shi, François Ferron, Bruno Canard
The guanosine analog AT-527 represents a promising candidate against Severe Acute Respiratory Syndrome coronavirus type 2 (SARS-CoV-2). AT-527 recently entered phase III clinical trials for the treatment of COVID-19. Once in cells, AT-527 is converted into its triphosphate form, AT-9010, that presumably targets the viral RNA-dependent RNA polymerase (RdRp, nsp12), for incorporation into viral RNA. Here we report a 2.98 Å cryo-EM structure of the SARS-CoV-2 nsp12-nsp7-nsp82 -RNA complex, showing AT-9010 bound at three sites of nsp12...
February 2, 2022: Nature Communications
https://read.qxmd.com/read/34876524/a-serum-stable-rna-aptamer-specific-for-sars-cov-2-neutralizes-viral-entry
#54
JOURNAL ARTICLE
Julián Valero, Laia Civit, Daniel M Dupont, Denis Selnihhin, Line S Reinert, Manja Idorn, Brett A Israels, Aleksandra M Bednarz, Claus Bus, Benedikt Asbach, David Peterhoff, Finn S Pedersen, Victoria Birkedal, Ralf Wagner, Søren R Paludan, Jørgen Kjems
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has created an urgent need for new technologies to treat COVID-19. Here we report a 2'-fluoro protected RNA aptamer that binds with high affinity to the receptor binding domain (RBD) of SARS-CoV-2 spike protein, thereby preventing its interaction with the host receptor ACE2. A trimerized version of the RNA aptamer matching the three RBDs in each spike complex enhances binding affinity down to the low picomolar range. Binding mode and specificity for the aptamer-spike interaction is supported by biolayer interferometry, single-molecule fluorescence microscopy, and flow-induced dispersion analysis in vitro...
December 14, 2021: Proceedings of the National Academy of Sciences of the United States of America
https://read.qxmd.com/read/34680368/selection-of-a-nuclease-resistant-rna-aptamer-targeting-cd19
#55
JOURNAL ARTICLE
Carla L Esposito, Katrien Van Roosbroeck, Gianluca Santamaria, Deborah Rotoli, Annamaria Sandomenico, William G Wierda, Alessandra Ferrajoli, Menotti Ruvo, George A Calin, Vittorio de Franciscis, Silvia Catuogno
The transmembrane glycoprotein cluster of differentiation 19 (CD19) is a B cell-specific surface marker, expressed on the majority of neoplastic B cells, and has recently emerged as a very attractive biomarker and therapeutic target for B-cell malignancies. The development of safe and effective ligands for CD19 has become an important need for the development of targeted conventional and immunotherapies. In this regard, aptamers represent a very interesting class of molecules. Additionally referred to as 'chemical antibodies', they show many advantages as therapeutics, including low toxicity and immunogenicity...
October 18, 2021: Cancers
https://read.qxmd.com/read/34637761/miro1-provides-neuroprotection-via-the-mitochondrial-trafficking-pathway-in-a-rat-model-of-traumatic-brain-injury
#56
JOURNAL ARTICLE
Chen Chen, Lina Lu, Jie Zhu, XiaoYu Gu, BoFei Liu, Di Li, Gang Chen
The outer mitochondrial membrane protein mitochondrial Rho-GTPase 1 (Miro1) is known to be involved in the regulation of mitochondrial transport required for neuronal protection. Previous reports established that disruption of Miro1-dependent mitochondrial movement could result in nervous system diseases such as Parkinson's disease and Alzheimer's disease. This study was designed to explore the expression and mechanisms of Miro1 in secondary brain injury after traumatic brain injury (TBI). A total of 115 male Sprague Dawley rats were used in the weight-drop TBI rat model, and Miro1 in vivo knockdown was performed 24 h before TBI modeling by treatment with Miro1 short-interfering RNA...
October 9, 2021: Brain Research
https://read.qxmd.com/read/34578320/rna-dependent-rna-polymerase-from-heterobasidion-rna-virus-6-is-an-active-replicase-in-vitro
#57
JOURNAL ARTICLE
Alesia A Levanova, Eeva J Vainio, Jarkko Hantula, Minna M Poranen
Heterobasidion RNA virus 6 (HetRV6) is a double-stranded (ds)RNA mycovirus and a member of the recently established genus Orthocurvulavirus within the family Orthocurvulaviridae . The purpose of the study was to determine the biochemical requirements for RNA synthesis catalyzed by HetRV6 RNA-dependent RNA polymerase (RdRp). HetRV6 RdRp was expressed in Escherichia coli and isolated to near homogeneity using liquid chromatography. The enzyme activities were studied in vitro using radiolabeled UTP. The HetRV6 RdRp was able to initiate RNA synthesis in a primer-independent manner using both virus-related and heterologous single-stranded (ss)RNA templates, with a polymerization rate of about 46 nt/min under optimal NTP concentration and temperature...
August 31, 2021: Viruses
https://read.qxmd.com/read/34575949/an-influence-of-modification-with-phosphoryl-guanidine-combined-with-a-2-o-methyl-or-2-fluoro-group-on-the-small-interfering-rna-effect
#58
JOURNAL ARTICLE
Anna S Pavlova, Kristina I Yakovleva, Anna V Epanchitseva, Maxim S Kupryushkin, Inna A Pyshnaya, Dmitrii V Pyshnyi, Elena I Ryabchikova, Ilya S Dovydenko
Small interfering RNA (siRNA) is the most important tool for the manipulation of mRNA expression and needs protection from intracellular nucleases when delivered into the cell. In this work, we examined the effects of siRNA modification with the phosphoryl guanidine (PG) group, which, as shown earlier, makes oligodeoxynucleotides resistant to snake venom phosphodiesterase. We obtained a set of siRNAs containing combined modifications PG/2'-O-methyl (2'-OMe) or PG/2'-fluoro (2'-F); biophysical and biochemical properties were characterized for each duplex...
September 10, 2021: International Journal of Molecular Sciences
https://read.qxmd.com/read/34522592/a-review-of-existing-strategies-for-designing-long-acting-parenteral-formulations-focus-on-underlying-mechanisms-and-future-perspectives
#59
REVIEW
Yujie Shi, An Lu, Xiangyu Wang, Zakia Belhadj, Jiancheng Wang, Qiang Zhang
The need for long-term treatments of chronic diseases has motivated the widespread development of long-acting parenteral formulations (LAPFs) with the aim of improving drug pharmacokinetics and therapeutic efficacy. LAPFs have been proven to extend the half-life of therapeutics, as well as to improve patient adherence; consequently, this enhances the outcome of therapy positively. Over past decades, considerable progress has been made in designing effective LAPFs in both preclinical and clinical settings. Here we review the latest advances of LAPFs in preclinical and clinical stages, focusing on the strategies and underlying mechanisms for achieving long acting...
August 2021: Acta Pharmaceutica Sinica. B
https://read.qxmd.com/read/34488577/rna-aptamers-for-theranostics-of-glioblastoma-of-human-brain
#60
JOURNAL ARTICLE
Alexey M Kopylov, Lika V Fab, Olga Antipova, Ekaterina A Savchenko, Alexander V Revishchin, Viktoriya V Parshina, Svetlana V Pavlova, Igor I Kireev, Andrey V Golovin, Dmitry Y Usachev, Galina V Pavlova
Conventional approaches for studying and molecular typing of tumors include PCR, blotting, omics, immunocytochemistry, and immunohistochemistry. The last two methods are the most used, as they enable detecting both tumor protein markers and their localizations within the cells. In this study, we have investigated a possibility of using RNA aptamers, in particular, 2'-F-pyrimidyl-RNA aptamer ME07 (48 nucleotides long), specific to the receptor of epidermal growth factor (EGFR, ErbB1, Her1), as an alternative to monoclonal antibodies for aptacytochemistry and aptahistochemistry for human glioblastoma multiforme (GBM)...
August 2021: Biochemistry. Biokhimii︠a︡
keyword
keyword
165347
3
4
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.